NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q2 2016. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,046,000 | -91.1% | 15,145 | -88.4% | 0.14% | -90.6% |
| Q3 2017 | $11,814,000 | +2.3% | 130,000 | -16.2% | 1.51% | -9.0% |
| Q2 2017 | $11,545,000 | +9.4% | 155,118 | +37.7% | 1.66% | -0.8% |
| Q1 2017 | $10,552,000 | +62.6% | 112,614 | +26.1% | 1.67% | +34.3% |
| Q4 2016 | $6,490,000 | -99.9% | 89,314 | +81.2% | 1.24% | +52.3% |
| Q3 2016 | $5,146,427,000 | +128400.0% | 49,300 | -9.2% | 0.82% | +14.9% |
| Q2 2016 | $4,005,000 | +256.0% | 54,300 | +171.5% | 0.71% | +218.8% |
| Q1 2016 | $1,125,000 | – | 20,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |